Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$331.41M
Total Bought:
$38.40M
Total Sold:
$233.83M
Net Transaction:
-$195.43M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Neurogene Inc.(NGNE)1,004,2911,004,2910$36.55M$42.14M12.72%+$5.59M
ABIVAX Société AnonymeADS(ABVX)2,472,1882,128,773-343,415$32.68M$24.52M7.40%-$8.16M
Pliant Therapeutics, Inc.(PLRX)2,636,8641,910,121-726,743$28.35M$21.41M6.46%-$6.93M
Evolus, Inc.(EOLS)2,451,7721,170,000-1,281,772$26.60M$18.95M5.72%-$7.65M
Viridian Therapeutics, Inc.(VRDN)500,000750,000+250,000$6.50M$17.06M5.15%+$10.56M
Cytokinetics, Incorporated(CYTK)474,202316,000-158,202$25.69M$16.68M5.03%-$9.01M
Kalvista Pharmaceuticals Inc1,338,5681,299,503-39,065$15.77M$15.05M4.54%-$720.1K
Dynavax Technologies Corp2,374,0001,326,234-1,047,766$26.66M$14.77M4.46%-$11.89M
Context Therapeutics Inc.(CNTX)7,419,3556,934,982-484,373$14.88M$13.59M4.10%-$1.28M
Zura Bio LimitedCL A(ZURA)4,642,2413,263,672-1,378,569$16.25M$13.25M4.00%-$3.00M
Oruka Therapeutics, Inc.(ORKA)0514,659+514,659$0$12.61M3.81%+$12.61M
Merus N V523,288250,000-273,288$30.96M$12.49M3.77%-$18.47M
Olema Pharmaceuticals, Inc.(OLMA)796,8801,000,000+203,120$8.62M$11.94M3.60%+$3.32M
Ionis Pharmaceuticals, Inc.(IONS)330,000255,000-75,000$15.73M$10.22M3.08%-$5.51M
Autolus Therapeutics plcADS(AUTL)3,441,6672,811,955-629,712$11.98M$10.21M3.08%-$1.77M
UroGen Pharma Ltd.(URGN)2,906,259758,786-2,147,473$48.77M$9.64M2.91%-$39.13M
Optinose Inc13,727,09712,861,136-865,961$14.28M$8.62M2.60%-$5.66M
Arcellx Inc
COMMON STOCK
492,000100,000-392,000$27.15M$8.35M2.52%-$18.80M
Dianthus Therapeutics, Inc.(DNTH)757,929275,000-482,929$19.62M$7.53M2.27%-$12.09M
Outlook Therapeutics, Inc.(OTLK)1,701,5101,293,028-408,482$12.56M$6.90M2.08%-$5.65M
Jasper Therapeutics, Inc.(JSPR)402,015322,380-79,635$9.13M$6.06M1.83%-$3.06M
Voyager Therapeutics, Inc.(VYGR)1,601,527959,953-641,574$12.67M$5.62M1.69%-$7.05M
Helix Acquisition Corp IiCL A500,000500,0000$5.11M$5.22M1.58%+$115.0K
TScan Therapeutics, Inc.(TCRX)940,8311,016,375+75,544$5.50M$5.06M1.53%-$442.3K
Unicycive Therapeutics Inc08,559,000+8,559,000$0$3.49M1.05%+$3.49M
Promis Neurosciences Inc02,790,698+2,790,698$0$3.49M1.05%+$3.49M
Cartesian Therapeutics, Inc.(RNAC)0200,000+200,000$0$3.22M0.97%+$3.22M
Vistagen Therapeutics, Inc.(VTGN)1,529,338674,075-855,263$5.32M$2.03M0.61%-$3.29M
Climb Bio, Inc.(CLYM)0248,168+248,168$0$1.26M0.38%+$1.26M
Amicus Therapeutics Inc
COM
1,495,5000-1,495,500$14.84M$0—-$14.84M
Anaptysbio Inc25,0000-25,000$626.5K$0—-$626.5K
Esperion Therapeutics Inc Ne5,791,5940-5,791,594$12.86M$0—-$12.86M
Insmed Incorporated(INSM)250,0000-250,000$16.75M$0—-$16.75M
Kyverna Therapeutics, Inc.(KYTX)499,1520-499,152$3.74M$0—-$3.74M
Lexicon Pharmaceuticals, Inc.(LXRX)30,0000-30,000$50.4K$0—-$50.4K
Puma Biotechnology, Inc.(PBYI)1,486,5440-1,486,544$4.85M$0—-$4.85M
Spyre Therapeutics, Inc.(SYRE)134,6120-134,612$3.16M$0—-$3.16M
Terns Pharmaceuticals Inc1,149,4060-1,149,406$7.83M$0—-$7.83M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q3 2024 | TickerTrail